Unclaimed brand
BioSymetrics is a phenomics-driven drug discovery company that integrates clinical and experimental data, using machine learning, to translate human disease biology and advance precision medicine. We are a remote-first company with offices in Boston and Toronto.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#F8C307
Corn
248, 195, 7
47, 95, 50
0, 21, 97, 3
#EA8082
Apricot
234, 128, 130
359, 72, 71
0, 45, 44, 8
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
BioSymetrics is a phenomics-driven drug discovery company that leverages clinical and experimental data using machine learning algorithms to advance precision medicines and translate human disease biology. Their platform, Elion, integrates various data sources, including electronic medical records and experimental data from zebrafish models captured through proprietary computer vision technology. By connecting these data sources, BioSymetrics identifies high-confidence targets for drug discovery that are rooted in human genetic evidence, doubling their likelihood of clinical success.
The company is actively working on programs in cardiometabolic, neurological, and rare diseases such as familial dilated cardiomyopathy, atherosclerosis, and epilepsy. With a remote-first approach, BioSymetrics operates with people clusters in Boston, Toronto, and San Francisco. Their team consists of a diverse group of entrepreneurs, machine learning experts, and R&D innovators, and they receive guidance from a distinguished advisory board of renowned scientists and technologists.
BioSymetrics is dedicated to translating data into groundbreaking discoveries in the field of precision medicine
